TREVI THERAPEUTICS INC's ticker is TRVI and the CUSIP is 89532M101. A total of 64 filers reported holding TREVI THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 1.67 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rosalind Advisors, Inc. | 1,862,425 | $2,495,650 | 2.06% |
| Checkpoint Capital L.P. | 1,292,316 | $1,731,703 | 1.05% |
| NEA Management Company, LLC | 11,370,376 | $15,236,304 | 1.02% |
| Opaleye Management Inc. | 2,535,000 | $3,396,900 | 0.90% |
| Tejara Capital Ltd | 1,269,000 | $1,700,460 | 0.71% |
| Frazier Life Sciences Management, L.P. | 7,381,090 | $9,890,661 | 0.53% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 863,883 | $1,157,603 | 0.34% |
| VR Adviser, LLC | 3,422,397 | $4,586,012 | 0.32% |
| Rubric Capital Management LP | 5,684,420 | $7,617,123 | 0.16% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 910,094 | $1,219,526 | 0.11% |